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Abstract Epidermal tissue repair represents a complex
series of temporal and dynamic events resulting in wound
closure. Matricellular proteins, not normally expressed in
quiescent adult tissues, play a pivotal role in wound repair
and associated extracellular matrix remodeling by modu-
lating the adhesion, migration, intracellular signaling, and
gene expression of inflammatory cells, pericytes, fibroblasts
and keratinocytes. Several matricellular proteins show
temporal expression during dermal wound repair, but the
expression pattern of the recently identified matricellular
protein, periostin, has not yet been characterized. The
primary aim of this study was to assess whether periostin
protein is present in healthy human skin or in pathological
remodeling (Nevus). The second aim was to determine if
periostin is expressed during dermal wound repair. Using
immunohistochemistry, periostin reactivity was detected in
the keratinocytes, basal lamina, and dermal fibroblasts in
healthy human skin. In pathological nevus samples,
periostin was present in the extracellular matrix. In
excisional wounds in mice, periostin protein was first
detected in the granulation tissue at day 3, with levels
peaking at day 7. Periostin protein co-localized with α-
smooth muscle actin-positive cells and keratinocytes, but
not CD68 positive inflammatory cells. We conclude that
periostin is normally expressed at the cellular level in
human and murine skin, but additionally becomes extracel-
lular during tissue remodeling. Periostin may represent a
new therapeutic target for modulating the wound repair
process.
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Introduction
Periostin comprised of 811-amino acids has been recently
classed as a matricellular protein (Hamilton 2008; Norris et
al. 2008a). Unlike many other members of the matricellular
protein family, periostin is expressed in adults, most
commonly in collagen-rich tissues (Hamilton 2008), where
its expression is often associated with fibroblasts (Tilman et
al. 2007). Analysis of the periostin null mouse suggests that
periostin is fibrogenic, as significant abnormalities in the
atrioventricular valve points to a role for periostin in the
differentiation of the cushion mesenchyme into
myofibroblastic-valve tissue (Butcher et al. 2007;L i e -
Venema et al. 2008; Norris et al. 2008b). Periostin has also
been shown to be prominently upregulated during extracel-
lular matrix (ECM) remodeling, including after myocardial
infarction (Kuhn et al. 2007; Shimazaki et al. 2008), in
bone marrow fibrosis (Oku et al. 2008) and during
pulmonary vascular remodeling (Chen et al. 2006). It
therefore appears that periostin is an important regulator
of fibroblast differentiation and ECM remodeling in both
normal and pathological tissues.
The excisional full thickness dermal wound model is a
powerful tool for understanding how individual proteins
contribute to the wound repair process (Basu et al. 2001;
Cowin et al. 2001; Jarvelainen et al. 2006). While
collagens, fibrin and fibronectin provide structural support
during dermal wound repair, it is has been shown that
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modulate the adhesion, proliferation and differentiation of
inflammatorycells,fibroblasts,pericytes,andendothelialcells
(Midwood et al. 2004). Matricellular proteins including
g a l e c t i n s( E l o l ae ta l .2007), thrombospondins (Puolakkainen
et al. 2005), syndecans (Midwood et al. 2004), SPARC
(Reed et al. 1993) and tenascin-C (Latijnhouwers et al. 1996)
appear in the provisional matrix and influence matrix
deposition, angiogenesis, cell maturation and wound con-
traction up to 15 days post injury. At the onset of late
inflammation and the initiation of the proliferative phase of
wound repair (days 5–7), fibroblasts migrate through the
loose granulation tissue matrix, which is composed of
collagen types I, III and IV, fibrin, fibronectin and
hyaluronan (Agren and Werthen 2007). Concurrent with this
migration, fibroblasts undergo a phenotypic change, becom-
ing α-smooth muscle actin (α-SMA)-expressing myofibro-
blasts, facilitating contraction of the wound edge
(Desmouliere et al. 2005;G a b b i a n i2003). Given that it
appears to be pro-fibrogenic, we hypothesized that periostin
would be expressed in granulation tissue formed in response
to experimentally induced excisional wounds. However,
whether periostin is expressed in dermal wound repair has
yet to be shown.
The aim of this study was two fold: 1) to determine if
periostin is expressed in healthy and pathological human
skin and; 2) to assess the expression and localization of
periostin during excisional dermal wound repair. Using
immunhistochemistry, we identified that periostin is
expressed in normal human and murine skin. Furthermore,
periostin is expressed in the remodeling ECM formed
during wound repair where it is associated with myofibro-
blasts. We conclude that periostin is expressed in healthy
skin as well as in ECM remodeling in response to
pathology and dermal wound repair.
Materials and methods
Animals
All studies involving mice were performed in compliance
with the University Council on Animal Care at the
University of Western Ontario under approved protocols.
Serological analyses were performed on the mice prior to
experiments to test for the presence of blood borne
pathogens or infection. For experiments, mice were housed
in individual cages and maintained under a 12 h light/dark
cycle and temperature in accordance with the guidelines of
the Canadian Council on Animal Care. For wounding
experiments, eight male C57/BL6 mice (7–8 weeks of age
weighing approximately 25 g) were anesthetized with an
intraperitoneal injection containing ketamine (75 mg/kg)
and xylazine (5 mg/kg). The backs were cleaned, shaved,
and sterilized with betadine solution. Two full-thickness
wounds through the epidermis and dermis were made on
both sides of the dorsal midline, using a 5 mm punch
biopsy. Animals were sacrificed at 0, 3, 7, 21 and 28 days
post wounding for histological analysis.
Sample preparation and immunohistochemistry
Formalin fixed, paraffin embedded skin and nevus samples
were drawn from the archives of the Oral Pathology
Diagnostic Service, University of Western Ontario. Skin
samples from mice were prepared, fixed and embedded as
previously described (Leask et al. 2008). The specimens
were examined for the expression of periostin using
standard in situ immunohistochemical techniques. 5 µm
sections were cut from each block using a microtome and
placed on positively charged slides (Fisher scientific),
which were dried overnight in an oven at 42°C. To stain
sections for periostin, sections were rehydrated and then
quenched in 3% hydrogen peroxide in methanol for 5 min.
Each section was then rinsed in H2O, followed by
phosphate buffered saline (PBS) for 5 min. Sections were
blocked with 10% horse serum in PBS for 30 min at room
temperature in a humidified chamber. Excess horse serum
was removed and sections were incubated with goat anti-
human periostin antibody (periostin S-15: sc-49480, Santa
Cruz Biotechnology, Inc.) at 1/200 dilution overnight at 4°C
in a humidified chamber. 10% horse serum with no primary
antibody was used as a control for each sample. Following
incubation, sections were rinsed in PBS for 5 min. Rinsed
sections were then incubated with ImmPress AntiGoat Ig
(Vector laboratories) for 30 min at room temperature in
humidified chamber, followed by a 5-minute wash in PBS.
Sections were visualized using the DAB substrate kit for
perioxidase (Vector Laboratories). The reaction was stopped
by rinsing sections in H2O. The sections were then counter-
stained in Harris hematoxylin for 1 min, rinsed in tap water,
and blued in ammonium alcohol. Sections were then rinsed
with tap H2O, and dehydrated by bringing them from water
through to xylene. Sections were coverslipped using Cyto-
seal (VWR). Slides were analyzed under light microscopy.
Culture of human dermal fibroblasts
Human dermal fibroblasts were isolated using an explant
technique as previously described (Chen et al. 2008). In
brief, explants were cultured on tissue-culture plastic in
alpha minimal essential medium (Stem cell Technology,
Vancouver, BC, Canada) supplemented with antibiotics
penicillin G, 100 mg/ml (Sigma, St. Louis, MO); gentami-
cin, 50 mg/ml (Sigma); Fungizone, 3 mg/ml (Gibco, Grand
Island, NY); and 15% fetal bovine serum (Flow, McLean,
126 L. Jackson et al.Fig. 1 Periostin is expressed in healthy and pathological human skin
samples.a In healthy skin, periostin is associated with dermal fibroblasts
and keratinocytes, but in nevus, periostin localizes within the
extracellular matrix, which is further evident at higher magnifications
shown in (b). Confirmation of periostin mRNA levels in human dermal
fibroblasts using Taqman polymerase chain reaction is shown in (c)
Periostin and wound repair 127VA) at 37°C in a humidified atmosphere of 95% air 5%
CO2. Once confluent, cells were removed from the growth
surface using a trypsin solution [0.25% trypsin (Gibco),
0.1% glucose, citrate-saline buffer (pH 7.8)]. Cells were
used between passage 2–5 for experiments.
Taqman realtime polymerase chain reaction
Total RNA was isolated using Trizol reagent (Invitrogen).
Total RNA (25 ng) was amplified using the TaqMan One
Step RT-PCR Master Mix (4309169; Applied Biosystems
Fig. 2 Immunohistochemical staining of periostin at 0, 3, 7, 21 and
28 days post wounding with a polyclonal antibody to periostin.
Periostin expression is evident in the granulation tissue at 3 days, with
levels peaking at 7 days. At day 7, the granulation tissue undergoes
remodeling and the wound begins to contract, suggesting a role for
periostin in both processes
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quantitative real-time PCR reactions were performed using
the Prism 7900 HT Sequence Detector (Applied Biosys-
tems Inc.). Samples were incubated at 48°C for 30 min to
make cDNA templates. The resulting cDNA was amplified
for 40 cycles. Cycles alternated between 95°C for 15 s and
60°C for 1 min. Results were analysed using SDS v2.1
software (Applied Biosystems Inc.). The ΔΔCt method
was used to calculate gene expression levels relative to
GAPDH and normalized to control cells. Data were log-
transformed prior to analysis by one-way analysis of
variance and Tukey’s post-hoc test, using Graphpad
Software v. 4 (Graphpad Software, La Jolla, CA, USA).
Results
Periostin localization in healthy human dermis and nevus
Using immunohistochemistry, we examined the localization
of periostin in healthy human skin and in nevus tissue, the
latter representing pathological remodeling of skin. In
healthy skin, periostin was detected predominantly in the
epidermis, where it localized to the nucleus of the
keratinocytes (Fig. 1a, b). Mature keratinocytes in the outer
epidermis did not stain positively for periostin. Fibroblasts
in the dermis also exhibited reactivity for periostin, which
we confirmed in cultured dermal fibroblasts using realtime
PCR for periostin mRNA (Fig. 1c). In nevus samples, the
localization of periostin was similar in the epidermal layer
to normal skin, but in the remodeled dermis, periostin was
detected predominantly in the extracellular matrix, where
periostin associated with large fibrils around the cells
(Fig. 1b).
Expression and localization of periostin in full thickness
dermal wounds
To assess the role of periostin in dermal wound repair, we
created full thickness dermal wounds in C57/BL6 mice
using a 5 mm biopsy punch (Figs. 2 and 3). In unwounded
skin (Day 0), periostin was detected in the hypodermis,
around hair follicles, as well as in the basal lamina.
Periostin reactivity was evident in a subset of keratinocyte
nuclei. After wounding, periostin reactivity was first
evident in the granulation tissue at day 3, with higher
levels evident in the migrating keratinocytes at the edge of
the wound, particularly associated with the nucleus. At day
Fig. 3 Immunohistochemical
staining of periostin at 0, 3, 7,
21 and 28 days post wounding
with a polyclonal antibody to
periostin. White arrows denote
nuclear localization of periostin.
Periostin expression is first evi-
dent in the granulation tissue
and keratinocytes at 3 days, with
levels peaking at 7 days and
returning to basal levels at
28 days
Periostin and wound repair 1297, migrating keratinocyes, which had already re-
epithelialized the wound, were highly reactive for periostin
protein. Furthermore, periostin protein was present in the
ECM of the remodeling dermis/granulation tissue. At day
21, periostin staining was evident only in the remodeling
matrix. Periostin protein levels returned to day 0 levels at
day 28 post-wounding.
Periostin expression correlates with an increase in α-SMA
As periostin has been previously associated with differen-
tiation of cushion mesenchyme into myofibroblastic valve
tissue (Norris et al. 2008b), we assessed whether periostin
protein in the remodeling granulation tissue and ECM was
associated with the presence of α-SMA associated myofi-
broblasts. At day 3, although periostin expression was
evident in the granulation tissue at low levels, only a few α-
SMA–positive myofibroblasts were detected migrating into
the tissue (Fig. 4a, b). The majority of cells in the
granulation tissue were CD68 positive denoting them as
macrophages (Fig. 4c, d). At day 7 where periostin protein
levels were highest, a significant increase in α-SMA was
evident (Fig. 5a–c), which also corresponded to the areas in
the wound bed where periostin expression was highest.
Discussion
Periostin is a secreted extracellular matrix protein, that has
been hypothesized to promote fibrogenic differentiation
(Erkan et al. 2007;N o r r i se ta l .2008a). In humans,
periostin expression is variable in normal healthy tissues,
but is most commonly associated with fibroblast-rich
tissues (Tilman et al. 2007). In this present study, we report
that periostin protein is expressed in both healthy and
pathological human and murine skin. Furthermore, perios-
tin is a significant component of the granulation tissue and
remodeling ECM formed during the repair of excisional
dermal wounds, where periostin is associated with α-SMA
myofibroblasts and keratinocytes.
Fig. 4 Periostin, α-SMA, and
CD68 localization at 3 days post
wounding. a and b α-SMA
associated fibroblasts can be
seen migrating into the granula-
tion tissue, with low levels of
periostin evident in the same
area (White arrows denote areas
of fibroblast migration). c In
other areas of the matrix not
associated with periostin ex-
pression, CD68 positive cells
are present which are cells of the
macrophage lineage
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associated with keratinocytes and dermal fibroblasts
(Fig. 1). Interestingly, we did not detect periostin reactivity
in the extracellular matrix of healthy dermis, suggesting it is
unlikely abundant expression of periostin is required for
maintenance of tissue homeostasis. However, the marked
switch of periostin protein localization from cells to the
ECM in pathological remodeling (nevus) compared to
healthy skin, suggests that periostin plays a role in
remodeling of tissues in response to pathological insult.
Periostin expression is now known to be prevalent in many
pathologies including cancer (Bao et al. 2004; Gillan et al.
2002; Ruan et al. 2009; Sasaki et al. 2001), bone marrow
fibrosis (Oku et al. 2008), and cardiac hypertrophy and
remodeling (Oka et al. 2007). In cancer, periostin has been
shown to increase both cell motility (Gillan et al. 2002) and
cell survival (Bao et al. 2004). Classed as a matricellular
protein (Norris et al. 2008a), periostin has been shown to
interact with cells through αVβ3 and αVβ5 integrins
(Gillan et al. 2002), with subsequent activation of down-
stream targets including, but not limited to the Akt/Protein
Kinase B pathways (Bao et al. 2004). Akt/Protein Kinase B
pathways are particularly associated with cell cycle progres-
sion (Yun et al. 2009), potentially implicating ECM-
associated periostin with proliferation. Interestingly, periostin
has been previously shown to induce proliferation of
polycystic kidney cells through αV integrins (Wallace et al.
2008), and as proliferation of fibroblasts is an integral part of
wound repair, it is possible that periostin mediates cell
division. Future experiments will assess if extracellular
periostin induces proliferation of dermal fibroblasts.
To further investigate the role of periostin in skin
homeostasis and remodeling, we utilized the well-
established excisional full thickness dermal wound repair
model in mice (DiPietro et al. 1995). Periostin protein
appeared in the provisional matrix at 3 days, but was most
Fig. 5 Periostin and α-SMA
localization in dermal wounds
at 7 days post wounding. a At
low magnifications, α-SMA is
evident throughout the wound
bed, as is periostin protein. At
higher magnifications, α-SMA
positive myofibroblasts and
periostin localize to b the area
under the epithelium, as well as
in c lower areas of the dermis. In
b white arrows indicate α-SMA
positive cells in the epithelial
layer
Periostin and wound repair 131prominent at 7 days post wounding. The appearance of
periostin was concurrent with an increase in α-SMA
positive fibroblasts, the cells responsible for contraction of
wounds and scarring (Hinz 2007). To our knowledge, this is
the first report that periostin is associated with myofibro-
blasts in dermal wound repair. Previous studies have
identified that periostin expression is significantly higher
in keloid or hyperplastic scars compared with normal skin
(Wang et al. 2007). Furthermore, presence of periostin
correlated with higher levels of transforming growth
factor beta-1 (TGF-β1) in keloid scars, suggesting that
periostin may be regulated by TGF-β1. Regulation of
periostin by TGF-β isoforms has been confirmed in
periosteum (Horiuchi et al. 1999), periodontal ligament
(Horiuchi et al. 1999; Rios et al. 2008), and recently in the
atrioventricular valve(Norris et al. 2009). Interestingly,
differentiation of fibroblasts into myofibroblasts is also
known to be regulated in part by TGF-β (Tuan et al. 1996),
opening the possibility that the expression of α-SMA and
periostin occur simultaneously due to the presence of TGF-
β in the wound bed. Whether periostin protein is required
for myofibroblast differentiation in dermal wounds has yet
to be determined, although previous studies of the
atrioventricular valve identified that periostin is essential
for differentiation of mesenchyme to α-SMA-containing
myofibroblasts (Norris et al. 2008b; Norris et al. 2009).
Periostin reactivity in the nucleus was evident in the
human keratinocytes and a subset of murine keratinocytes
in healthy skin. Nuclear localization of periostin has been
previously reported in carcinoma cells from a subset of
patients (12%), where nuclear localization correlated with
tumour size (Puglisi et al. 2008). Whether periostin
localization to the nucleus has any functional significance
has not yet been determined. To date, it is known that
alternate splicing of periostin results in four isoforms
(Horiuchi et al. 1999), with only isoform four actually
being secreted into the ECM (Simon J. Conway, personal
communication). It is possible that depending on splicing,
certain isoforms are present, some which may localize with
the nucleus, others with the ECM. Further experiments will
investigate the expression of each isoform in healthy and
pathological tissues.
In conclusion, periostin is expressed at basal levels in
healthy skin, where it likely plays a role in tissue
homeostasis. Furthermore, induction of ECM remodeling,
whether as a result of pathological insult (nevus) or
experimentally induced (punch wound) changes the local-
ization of periostin from the intracellular to extracellular
compartment. It is possible that periostin is required in the
ECM, stimulating remodeling of the matrix by directly
influencing cell adhesion and resulting cell behaviour. This
study provides further compelling evidence that periostin
functions as a matricellular protein.
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